Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

New treatments for common hair loss might be safer and more effective than current options.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

DHEA inhibits growth in both mouse and human melanoma cells but works differently in each.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.